About Oxytocin

Oxytocin is a nine-amino-acid peptide hormone produced naturally by the hypothalamus and released by the posterior pituitary. Clinically it’s used to induce labour and control postpartum haemorrhage. In research literature it’s studied across a different axis entirely — the behavioural and social-cognitive effects mediated by central oxytocin receptor binding.

Because oxytocin doesn’t cross the blood-brain barrier efficiently from peripheral injection, social-behavioural research almost exclusively uses the intranasal route, which provides direct CNS access via the olfactory and trigeminal pathways. Subcutaneous and IV routes are reserved for obstetric research where peripheral effects (uterine contraction) are the target.

Dosing observed in research literature

Route	Typical dose	Frequency	Research application
Intranasal	24–40 IU (≈ 40–67 mcg)	Single dose, 45 min pre-task	Social cognition, trust, empathy research
Intranasal — chronic	24 IU daily	Once or twice daily	Long-term behavioural research protocols
Subcutaneous	5–10 IU	Single dose	Obstetric / peripheral effect research

Unit conversion: 1 IU of oxytocin ≈ 1.67 mcg (based on the WHO international standard). A 24 IU dose is approximately 40 mcg of peptide.

Typical reconstitution protocols

Oxytocin research vials typically ship as 1 mg or 2 mg lyophilised powder. For intranasal use, the standard workflow is to reconstitute, decant into a calibrated nasal sprayer (0.1 mL per spray), and dose by spray count.

Vial size	BAC water	Concentration	Sprayer (0.1 mL/spray)	Per spray (mcg)
1 mg	2 mL	500 mcg/mL	10 sprays/mL	50 mcg (~30 IU)
1 mg	2.5 mL	400 mcg/mL	10 sprays/mL	40 mcg (~24 IU)
2 mg	4 mL	500 mcg/mL	10 sprays/mL	50 mcg (~30 IU)

The 1 mg vial + 2.5 mL BAC water sweet spot gives one spray ≈ 24 IU — matching the most-cited research dose exactly. See our nasal sprays guide for the full per-spray maths.

Half-life and frequency

Plasma half-life is very short — 3–5 minutes. But the CNS behavioural window after intranasal dosing extends to 45–90 minutes, with measurable effects on social-cognitive tasks documented up to 2 hours post-dose. This dissociation between plasma clearance and effect duration is typical of intranasal CNS-active peptides where the relevant compartment isn’t plasma.

For research protocols, dosing is typically single-event (45 minutes before a behavioural task) or once daily for chronic protocols. Twice-daily intranasal dosing is documented but not standard.

Storage and shelf life

Lyophilised: store at 2–8°C refrigerated. Reconstituted with bacteriostatic water: stable for up to 28 days refrigerated, though some sources recommend 14 days for nasal spray applications due to repeated sprayer-tip exposure. Never freeze a reconstituted vial.

Frequently asked questions

Why intranasal rather than injection?

Oxytocin crosses the blood-brain barrier poorly when injected peripherally. Intranasal administration uses the olfactory/trigeminal pathway to deliver oxytocin directly to the CNS, where its behavioural-research target sits. Subcutaneous oxytocin produces strong peripheral effects (uterine contraction) but minimal CNS effect.

How long until effects are measurable?

Most research protocols dose 45 minutes before behavioural assessment to allow CNS absorption and onset. Some social-cognition effects are detectable within 30 minutes; sustained effects extend to 90–120 minutes post-dose.

Can oxytocin be combined with other intranasal peptides?

Multi-peptide intranasal protocols exist in research but require separate spray bottles per compound — mixing different peptides in one sprayer changes their respective concentrations and isn’t recommended. Standard practice: one sprayer per compound, dose sequentially with 5 minutes between to allow each to absorb.

Does oxytocin affect blood pressure?

At intranasal research doses (24–40 IU), cardiovascular effects are minimal. At higher injectable doses (used clinically for labour induction), transient BP changes are documented. Research protocols using injectable oxytocin typically include cardiovascular monitoring.

What’s the IU to mcg conversion?

1 IU oxytocin ≈ 1.67 mcg. So 24 IU ≈ 40 mcg, 30 IU ≈ 50 mcg, 40 IU ≈ 67 mcg. The conversion is based on the WHO International Standard and is consistent across research literature.

How should the nasal sprayer be primed?

Pump 3–5 times into a tissue until a consistent mist forms. The first sprays after assembly are partly air. See our nasal sprays guide for the full setup workflow.

Related compounds

Oxytocin sits in the specialty research category. Adjacent intranasal cognitive peptides: Selank and Semax (both intranasal CNS-active, different mechanisms). PT-141 is another melanocortin-family neuropeptide. For full category context: “/compounds/specialty/”>Specialty Research Compounds.